ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
Adial Pharmaceuticals Inc

Adial Pharmaceuticals Inc (ADIL)

0.96
-0.08
(-7.69%)
마감 18 1월 6:00AM
0.9999
0.0399
(4.16%)
시간외 거래: 9:43AM

개인 투자자를 위한 전문가급 도구.

주요 통계 및 세부정보

가격
0.9999
매수가
0.99
매도가
1.00
거래량
100,988
0.96 일간 변동폭 1.025
0.765 52주 범위 4.12
market_cap
전일 종가
1.04
개장가
1.02
최근 거래 시간
100
@
0.9999
(formt)
마지막 거래 시간
재정 규모
US$ 101,316
VWAP
1.0032
평균 볼륨(3m)
164,934
발행 주식
6,405,781
배당수익률
-
주가수익률
-1.20
주당순이익(EPS)
-0.8
매출
-
순이익
-5.12M

Adial Pharmaceuticals Inc 정보

Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder.

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
본부
Wilmington, Delaware, USA
설립됨
-
Adial Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker ADIL. The last closing price for Adial Pharmaceuticals was US$1.04. Over the last year, Adial Pharmaceuticals shares have traded in a share price range of US$ 0.765 to US$ 4.12.

Adial Pharmaceuticals currently has 6,405,781 shares in issue. The market capitalisation of Adial Pharmaceuticals is US$6.66 million. Adial Pharmaceuticals has a price to earnings ratio (PE ratio) of -1.20.

ADIL 최신 뉴스

Adial Pharmaceuticals Granted Key U.S. Patent for the Treatment of Alcohol and Drug Dependence Based on Expanded Genotype Combinations

GLEN ALLEN, Va., Dec. 03, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.0351-3.391304347831.0351.05830.96543001.02244561CS
4-0.0321-3.110465116281.0321.130.96801561.04128029CS
12-0.1001-9.11.11.30.961649341.09249798CS
26-0.1101-9.918918918921.1130.914610971.27740936CS
52-0.4701-31.97959183671.474.120.76523246131.96148073CS
156-64.5001-98.473435114565.565.750.76511573145.7462835CS
260-51.5001-98.095428571452.51270.765101276224.12563324CS

ADIL - Frequently Asked Questions (FAQ)

What is the current Adial Pharmaceuticals share price?
The current share price of Adial Pharmaceuticals is US$ 0.9999
How many Adial Pharmaceuticals shares are in issue?
Adial Pharmaceuticals has 6,405,781 shares in issue
What is the market cap of Adial Pharmaceuticals?
The market capitalisation of Adial Pharmaceuticals is USD 6.66M
What is the 1 year trading range for Adial Pharmaceuticals share price?
Adial Pharmaceuticals has traded in the range of US$ 0.765 to US$ 4.12 during the past year
What is the PE ratio of Adial Pharmaceuticals?
The price to earnings ratio of Adial Pharmaceuticals is -1.2
What is the reporting currency for Adial Pharmaceuticals?
Adial Pharmaceuticals reports financial results in USD
What is the latest annual profit for Adial Pharmaceuticals?
The latest annual profit of Adial Pharmaceuticals is USD -5.12M
What is the registered address of Adial Pharmaceuticals?
The registered address for Adial Pharmaceuticals is CORPORATION TRUST CENTER 1209 ORANGE ST, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Adial Pharmaceuticals website address?
The website address for Adial Pharmaceuticals is www.adialpharma.com
Which industry sector does Adial Pharmaceuticals operate in?
Adial Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
BTCTBTC Digital Ltd
US$ 8.2697
(73.73%)
61.45M
BDMDBaird Medical Investment Holdings Ltd
US$ 8.80
(62.36%)
18.63M
CRKNCrown Electrokinetics Corporation
US$ 0.1235
(54.96%)
764.86M
NUKKNukkleus Inc
US$ 29.97
(45.98%)
19.09M
GSITGSI Technology
US$ 3.97
(44.36%)
87.7M
DOGZDogness International Corporation
US$ 18.23
(-58.77%)
740.45k
ORKTOrangeKloud Technology Inc
US$ 3.02
(-24.88%)
21.08M
PMAXPowell Max Ltd
US$ 0.6364
(-23.31%)
4.17M
LGCBLinkage Global Inc
US$ 0.2876
(-22.27%)
890.66k
YYAIConnexa Sports Technologies Inc
US$ 0.8299
(-20.20%)
602.48k
CRKNCrown Electrokinetics Corporation
US$ 0.1235
(54.96%)
764.86M
GCTKGlucoTrack Inc
US$ 0.0852
(15.45%)
465.22M
RIMEAlgorhythm Holdings Inc
US$ 0.0406
(-4.02%)
387.23M
TGLTreasure Global Inc
US$ 0.2459
(14.75%)
267.1M
NVDANVIDIA Corporation
US$ 137.71
(3.10%)
201.4M

ADIL Discussion

게시물 보기
Awl416 Awl416 6 월 전
Adial Pharmaceuticals Files New Patent Application to Protect Core Assets and Extend IP Exclusivity on Core Technology to 2044
👍️0
FROZENFLAME FROZENFLAME 6 월 전
Looks like green very soon !
👍️0
FROZENFLAME FROZENFLAME 6 월 전
Interesting !
👍️0
glenn1919 glenn1919 6 월 전
ADIL............................https://stockcharts.com/h-sc/ui?s=ADIL&p=W&b=5&g=0&id=p86431144783
👍️0
tw0122 tw0122 6 월 전
Adial Pharmaceuticals Advances to Second Cohort in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder

Source: GlobeNewswire Inc.

Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, announced the progression to the second cohort in the pharmacokinetics study of AD04, the Company’s lead investigational genetically targeted, serotonin-3 receptor antagonist, therapeutic agent for the treatment of Alcohol Use Disorder (AUD) in heavy drinking patients (defined as < 10 drinks/drinking day), following the successful completion of the first cohort. Topline results from both cohorts are expected to be announced during the fourth quarter of 2024.
Cary Claiborne, President and Chief Executive Officer of Adial commented, “We are pleased with the progress of our pharmacokinetics study of AD04. The successful completion of the first cohort allows us to advance to the second cohort as planned, staying on track with our projected timeline. The results from both cohorts will offer invaluable insights that are critical for the design of our upcoming Phase 3 Clinical Trial. We anticipate engaging with the FDA following receipt of the topline data from this study and seek their feedback on the overall design of our Phase 3 program.”

The pharmacokinetics study was initiated in June 2024 and is expected to be completed during the fourth quarter of 2024. The single-center open-label relative bioavailability and dose proportionality study will enroll up to 30 healthy adult volunteers and compare the pharmacokinetic profile of AD04 when administered as an oral dose of 0.33 mg with or without food against a reference standard product. This study will provide valuable information on the pharmacokinetic properties of AD04.

👍️0
Monksdream Monksdream 6 월 전
ADIL under $2
👍️0
Monksdream Monksdream 6 월 전
ADIL under $2
👍️0
glenn1919 glenn1919 8 월 전
ADIL....................https://stockcharts.com/h-sc/ui?s=ADIL&p=W&b=5&g=0&id=p86431144783
👍️0
Monksdream Monksdream 9 월 전
ADIL under $1
👍️0
Awl416 Awl416 9 월 전
What leaked?
👍️0
44Skell 44Skell 9 월 전
Where to now ADIL?
👍️0
Klinsmann Klinsmann 9 월 전
Sorry to say, I was deadly wrong on this one... But I´m holding and adding.
👍️0
Klinsmann Klinsmann 9 월 전
Holding up very well. And flagging for the next uptick. Jep, it‘s supposed to happen…
👍️ 1
44Skell 44Skell 9 월 전
Isn’t this stock suppose to be ticking up
👍️0
Invest-in-America Invest-in-America 9 월 전
ADIL: Boy, am I eatin' 'CROW' on this one, or what!!! (Likely Close today at $5.00, just to humiliate me even more!!!)


"Heck, I trash a stock, & then it soars to the MOON!!! I HATE when this happens!!! NO RESPECT, at all!!!"
🤣 1
glenn1919 glenn1919 9 월 전
ADIL...............................https://stockcharts.com/h-sc/ui?s=ADIL&p=W&b=5&g=0&id=p86431144783
👍️0
Invest-in-America Invest-in-America 9 월 전
ADIL: This is what one gets behind 'investing' in a mere Ultra-Pre-Human-Trials, Petri Dish, Test Tude, Theoretical Journal Paper, and otherwise, 'THE-GREAT-ALCOHOL-ADDICTION-MAYBE-COULD-BE-MIGHT-BE-YEARS-FROM-NOW-CURE-OF-THE-WEEK', fluffy, Wall Street 'news' routine.
👍️0
TheFinalCD TheFinalCD 9 월 전
tHANKS adiL 1.82
👍️0
Klinsmann Klinsmann 9 월 전
Congrats- chart looks primed for more…
👍️0
TheFinalCD TheFinalCD 9 월 전
filled 1.97 on that dip
👍️0
TheFinalCD TheFinalCD 9 월 전
$ADIL 2.54 LET MORE GO, WHAT A GREAT STOCK TO TRADE

https://finviz.com/quote.ashx?t=ADIL&ty=c&ta=1&p=d

https://twitter.com/READY_2_PROFIT/status/1778040234178920694
👍️0
TheFinalCD TheFinalCD 9 월 전
CONGRAT$
👍️0
TheFinalCD TheFinalCD 9 월 전
nhod https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174209695
👍️0
Klinsmann Klinsmann 9 월 전
Overdue- go time again!
👍️0
Awl416 Awl416 9 월 전
What leaked?
👍️0
Klinsmann Klinsmann 10 월 전
Added more shares - rumors about a big pharma deal hopefully get published soon…
👍️0
Monksdream Monksdream 10 월 전
ADIL 10Q due 3/18
👍️0
maent maent 10 월 전
I'm totally out. It was a nice bounce. We will see if it drops back into a buy zone. GL all.
👍️0
Bill_ENG Bill_ENG 11 월 전
Except for the failed Phase III and then the company not doing anything except for a reverse split in two years.

They need to run more trials it will take 3 to 4 years to prove effectiveness and a higher probability it will fail those trials.

Having a patent on something that doesn't work is not worth much.

Jmho
👍️0
glenn1919 glenn1919 11 월 전
ADIL................................................https://stockcharts.com/h-sc/ui?s=ADIL&p=W&b=5&g=0&id=p86431144783
👍️0
Lottoplay Lottoplay 11 월 전
“AD04 is also believed to have the potential to treat other addictive disorders such as Opioid Use Disorder, gambling, and obesity” my projected selling price just went higher! I didn’t know it treated gambling and obesity in addition to alcoholism and opioid addiction! BOOM!!!
👍️0
Lottoplay Lottoplay 11 월 전
BOOM! Posted yesterday! “ADIL this company has the potential to be worth #BILLIONS and at the same time help alcoholics and opioid addicts! Making money and helping humanity, who doesn’t want to be a part of that!”
👍️0
maent maent 11 월 전
I'm now looking for a nice bounce over $5
👍️0
BurgerKing82 BurgerKing82 11 월 전
This one looks good
👍️0
Lottoplay Lottoplay 11 월 전
$ADIL this company has the potential to be worth #BILLIONS and at the same time help alcoholics and opioid addicts! Making money and helping humanity, who doesn’t want to be a part of that! 🚀
👍️0
Awl416 Awl416 11 월 전
Adial Pharmaceuticals Awarded New Patent from the United States Patent and Trademark Office
👍️0
maent maent 11 월 전
I'm looking for a nice bounce back over $1
👍️0
Monksdream Monksdream 11 월 전
ADIL new 52 week low
👍️0
maent maent 11 월 전
My stop loss hit at 1.04
👍️0
Monksdream Monksdream 11 월 전
ADIL new 52 week low
👍️0
Monksdream Monksdream 11 월 전
ADIL new 52 week low
👍️0
maent maent 11 월 전
Looks like a nice entry point here.
👍️0
eb0783 eb0783 11 월 전
Cat got your tongue?
👍️0
Monksdream Monksdream 11 월 전
ADIL new 52 week low
👍️0
Monksdream Monksdream 11 월 전
ADIL new 52=week low
👍️0
Monksdream Monksdream 11 월 전
ADIL new 52 week low
🌈 1 🍆 1 👎️ 1 🩳 1
Monksdream Monksdream 12 월 전
ADIL new 52 week high
👍️0
Monksdream Monksdream 12 월 전
ADIL new 52 week low
👍️0
Muhbruh Muhbruh 1 년 전
https://twitter.com/StocksGambino/status/1740752941974438075
👍️0
Zorro Zorro 1 년 전
Volume picking up but also dropping in price. Looks like there is historic support in the 1.80 area.
👍️0

최근 히스토리

Delayed Upgrade Clock